Evidence map›Paper›PMID 37900150›Full record

ArticleFrontiers in endocrinology2023

CRH-R2 signalling modulates feeding and circadian gene expression in hypothalamic mHypoA-2/30 neurons.

Viridiana Alcántara-Alonso, Robert Dallmann, Hendrik Lehnert, Patricia de Gortari, Dimitris K Grammatopoulos

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Viridiana Alcántara-AlonsoTranslational Medicine, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Robert DallmannTranslational Medicine, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Hendrik LehnertRectorate, Paris Lodron Universität Salzburg, Salzburg, Austria.
Patricia de GortariLaboratorio de Neurofisiología Molecular, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.
Dimitris K GrammatopoulosTranslational Medicine, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Instituto Nacional de Psiquiatría · MXUniversity Hospitals Coventry and Warwickshire NHS Trust · GBUniversity of Salzburg · ATUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hypothalamic type 2 corticotropin releasing hormone receptor (CRH-R2) plays critical roles in homeostatic regulation, particularly in fine tuning stress recovery. During acute stress, the CRH-R2 ligands CRH and urocortins promote adaptive responses and feeding inhibition. However, in rodent models of chronic stress, over-exposure of hypothalamic CRH-R2 to its cognate agonists is associated with urocortin 2 (Ucn2) resistance; attenuated cAMP-response element binding protein (CREB) phosphorylation and increased food intake. The molecular mechanisms involved in these altered CRH-R2 signalling responses are not well described. In the present study, we used the adult mouse hypothalamus-derived cell line mHypoA-2/30 to investigate CRH-R2 signalling characteristics focusing on gene expression of molecules involved in feeding and circadian regulation given the role of clock genes in metabolic control. We identified functional CRH-R2 receptors expressed in mHypoA-2/30 cells that differentially regulate CREB and AMP-activated protein kinase (AMPK) phosphorylation and downstream expression of the appetite-regulatory genes proopiomelanocortin (

Indexed as

Corticotropin-Releasing HormoneReceptors, Corticotropin-Releasing HormoneAnimalsGene ExpressionHypothalamusMiceNeuronsUrocortinsCorticotropin-Releasing HormoneCRF receptor type 2Receptors, Corticotropin-Releasing HormoneUrocortinsAMPKcircadian rhythmCREBCRH-R2Feedinghypothalamic peptidesurocortin 2 (UCN2)

Identifiers

PMID37900150
PMCPMC10600019
OpenAlexW4387518897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.